These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22964903)

  • 1. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation.
    Taketa T; Correa AM; Suzuki A; Blum MA; Chien P; Lee JH; Welsh J; Lin SH; Maru DM; Erasmus JJ; Bhutani MS; Weston B; Rice DC; Vaporciyan AA; Hofstetter WL; Swisher SG; Ajani JA
    Oncology; 2012; 83(5):300-4. PubMed ID: 22964903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation.
    Taketa T; Xiao L; Sudo K; Suzuki A; Wadhwa R; Blum MA; Lee JH; Weston B; Bhutani MS; Skinner H; Komaki R; Maru DM; Rice DC; Swisher SG; Hofstetter WL; Ajani JA
    Oncology; 2013; 85(2):95-9. PubMed ID: 23860252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance Following Treatment of Esophageal Cancer.
    Bakhos CT; Acevedo E; Petrov RV; Abbas AE
    Surg Clin North Am; 2021 Jun; 101(3):499-509. PubMed ID: 34048769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
    Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.
    Hayashi Y; Xiao L; Suzuki A; Blum MA; Sabloff B; Taketa T; Maru DM; Welsh J; Lin SH; Weston B; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Ajani JA
    Eur J Cancer; 2012 Dec; 48(18):3396-404. PubMed ID: 22853875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.
    Cheedella NK; Suzuki A; Xiao L; Hofstetter WL; Maru DM; Taketa T; Sudo K; Blum MA; Lin SH; Welch J; Lee JH; Bhutani MS; Rice DC; Vaporciyan AA; Swisher SG; Ajani JA
    Ann Oncol; 2013 May; 24(5):1262-6. PubMed ID: 23247658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    Gronnier C; Piessen G; Mariette C
    J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Jeong Y; Kim JH; Kim SB; Yoon DH; Park SI; Kim YH; Kim HR; Jung HY; Lee GH; Ryu JS
    J Surg Oncol; 2014 Apr; 109(5):472-7. PubMed ID: 24301552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.
    Suzuki A; Xiao L; Taketa T; Sudo K; Wadhwa R; Blum MA; Skinner H; Komaki R; Weston B; Lee JH; Bhutani MS; Rice DC; Maru DM; Erasmus J; Swisher SG; Hofstetter WL; Ajani JA
    Ann Oncol; 2013 Nov; 24(11):2854-9. PubMed ID: 23994746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
    Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
    Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
    Hölscher AH; Fetzner UK
    Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
    Mönig SP; Berlth F; Chon SH
    Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
    [No Abstract]   [Full Text] [Related]  

  • 17. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
    Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
    Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of
    Arnett ALH; Merrell KW; Macintosh EM; James SE; Nathan MA; Shen KR; Ravi K; Neben Wittich MA; Haddock MG; Hallemeier CL
    J Thorac Oncol; 2017 Jan; 12(1):121-128. PubMed ID: 27569732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of surveillance following curative intent therapy for gastroesophageal cancer.
    Peixoto RD; Lim HJ; Kim H; Abdullah A; Cheung WY
    J Gastrointest Cancer; 2014 Sep; 45(3):325-33. PubMed ID: 24756830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.